Posted on March 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on March 7, 20243/7/24
Harnessing the Commercial Promise of Prescription Drug Use-Related Software (PDURS)
Posted on March 7, 20243/7/24
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Posted on March 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
Posted on February 29, 20242/29/24
Leveraging the Expertise of Medical Affairs to Create Global Value with Efficient, Cross-functional Collaboration
Posted on February 26, 20242/26/24
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Posted on January 30, 20241/30/24
Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act
Posted on January 23, 20241/23/24
Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on January 22, 20241/22/24